Clopidogrel – a popular antiplatelet drug widely used in treatment of various vascular diseases – is known for its favourable safety profile. Thrombotic thromocytopenic purpura (TTP) is very rare but serious adverse reaction associated with clopidogrel. We present a case of patient treated with clopidogrel who developed moderate TTP with leukopenia and symptoms of haemorrhagic diathesis
Thrombotic thrombocytopenic purpura (TTP) is a rare condition but associated with 90 % mortality if ...
Clopidogrel is a second generation of thienopyridine, which has antiplatelet effect by inhibiting P2...
Thienopyridines are commonly used antiplatelet drugs that may be associated with the development of ...
Clopidogrel – a popular antiplatelet drug widely used in treatment of various vascular disease...
We report a case of moderate thrombocytopenia associated with purpura-like phenomenon (four ecchymos...
Introduction In 1991, Page and colleagues published a report of four cases of thrombotic thrombocyto...
BACKGROUND: The antiplatelet drug clopidogrel is a new thienopyridine derivative whose mechanism of ...
Clopidogrel is used as a frontline antiplatelet drug in patients with coronary artery disease, peri-...
Clopidogrel has been reported to be safe and effective in reducing vascular events. Nevertheless, th...
Clopidogrel is a new oral antiplatelet agent with a structure and mechanism of action similar to tic...
Clopidogrel is a new oral antiplatelet agent with structure and mechanism of action similar to ticlo...
Thrombotic thrombocytopenic purpura (TTP) is a rare multisystem disease, characterized by thrombocyt...
Clopidogrel is an adenosine diphosphate receptor antagonist used for the prevention of vascular even...
We present the case of an 84-year-old female patient admitted to the Internal Medicine Ward for atyp...
INTRODUCTION: Clopidogrel is frequently associated with thrombotic thrombocytopenic purpura, however...
Thrombotic thrombocytopenic purpura (TTP) is a rare condition but associated with 90 % mortality if ...
Clopidogrel is a second generation of thienopyridine, which has antiplatelet effect by inhibiting P2...
Thienopyridines are commonly used antiplatelet drugs that may be associated with the development of ...
Clopidogrel – a popular antiplatelet drug widely used in treatment of various vascular disease...
We report a case of moderate thrombocytopenia associated with purpura-like phenomenon (four ecchymos...
Introduction In 1991, Page and colleagues published a report of four cases of thrombotic thrombocyto...
BACKGROUND: The antiplatelet drug clopidogrel is a new thienopyridine derivative whose mechanism of ...
Clopidogrel is used as a frontline antiplatelet drug in patients with coronary artery disease, peri-...
Clopidogrel has been reported to be safe and effective in reducing vascular events. Nevertheless, th...
Clopidogrel is a new oral antiplatelet agent with a structure and mechanism of action similar to tic...
Clopidogrel is a new oral antiplatelet agent with structure and mechanism of action similar to ticlo...
Thrombotic thrombocytopenic purpura (TTP) is a rare multisystem disease, characterized by thrombocyt...
Clopidogrel is an adenosine diphosphate receptor antagonist used for the prevention of vascular even...
We present the case of an 84-year-old female patient admitted to the Internal Medicine Ward for atyp...
INTRODUCTION: Clopidogrel is frequently associated with thrombotic thrombocytopenic purpura, however...
Thrombotic thrombocytopenic purpura (TTP) is a rare condition but associated with 90 % mortality if ...
Clopidogrel is a second generation of thienopyridine, which has antiplatelet effect by inhibiting P2...
Thienopyridines are commonly used antiplatelet drugs that may be associated with the development of ...